India · Delayed Price · Currency is INR NSE:ADVENZYMES Statistics
Total Valuation
NSE:ADVENZYMES has a market cap or net worth of INR 36.94 billion. The enterprise value is 30.72 billion.
| Market Cap | 36.94B |
| Enterprise Value | 30.72B |
Important Dates
The next confirmed earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
NSE:ADVENZYMES has 111.98 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 111.98M |
| Shares Outstanding | 111.98M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 39.84% |
| Owned by Institutions (%) | 13.66% |
| Float | 36.76M |
Valuation Ratios
The trailing PE ratio is 21.90 and the forward PE ratio is 21.28. NSE:ADVENZYMES's PEG ratio is 1.32.
| PE Ratio | 21.90 |
| Forward PE | 21.28 |
| PS Ratio | 4.95 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 3.04 |
| P/FCF Ratio | 35.33 |
| P/OCF Ratio | 23.56 |
| PEG Ratio | 1.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.69, with an EV/FCF ratio of 29.38.
| EV / Earnings | 18.21 |
| EV / Sales | 4.12 |
| EV / EBITDA | 13.69 |
| EV / EBIT | 16.21 |
| EV / FCF | 29.38 |
Financial Position
The company has a current ratio of 9.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.78 |
| Quick Ratio | 7.97 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.31 |
| Interest Coverage | 72.10 |
Financial Efficiency
Return on equity (ROE) is 11.02% and return on invested capital (ROIC) is 14.34%.
| Return on Equity (ROE) | 11.02% |
| Return on Assets (ROA) | 6.85% |
| Return on Invested Capital (ROIC) | 14.34% |
| Return on Capital Employed (ROCE) | 10.94% |
| Weighted Average Cost of Capital (WACC) | 8.04% |
| Revenue Per Employee | 18.23M |
| Profits Per Employee | 4.13M |
| Employee Count | 409 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, NSE:ADVENZYMES has paid 589.28 million in taxes.
| Income Tax | 589.28M |
| Effective Tax Rate | 25.34% |
Stock Price Statistics
The stock price has increased by +1.51% in the last 52 weeks. The beta is 0.69, so NSE:ADVENZYMES's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +1.51% |
| 50-Day Moving Average | 359.41 |
| 200-Day Moving Average | 316.82 |
| Relative Strength Index (RSI) | 42.33 |
| Average Volume (20 Days) | 465,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ADVENZYMES had revenue of INR 7.46 billion and earned 1.69 billion in profits. Earnings per share was 15.06.
| Revenue | 7.46B |
| Gross Profit | 5.38B |
| Operating Income | 1.89B |
| Pretax Income | 2.33B |
| Net Income | 1.69B |
| EBITDA | 2.17B |
| EBIT | 1.89B |
| Earnings Per Share (EPS) | 15.06 |
Balance Sheet
The company has 7.05 billion in cash and 320.09 million in debt, with a net cash position of 6.73 billion or 60.09 per share.
| Cash & Cash Equivalents | 7.05B |
| Total Debt | 320.09M |
| Net Cash | 6.73B |
| Net Cash Per Share | 60.09 |
| Equity (Book Value) | 16.83B |
| Book Value Per Share | 145.81 |
| Working Capital | 9.37B |
Cash Flow
In the last 12 months, operating cash flow was 1.57 billion and capital expenditures -522.30 million, giving a free cash flow of 1.05 billion.
| Operating Cash Flow | 1.57B |
| Capital Expenditures | -522.30M |
| Depreciation & Amortization | 275.13M |
| Net Borrowing | -91.20M |
| Free Cash Flow | 1.05B |
| FCF Per Share | 9.34 |
Margins
Gross margin is 72.20%, with operating and profit margins of 25.41% and 22.62%.
| Gross Margin | 72.20% |
| Operating Margin | 25.41% |
| Pretax Margin | 31.18% |
| Profit Margin | 22.62% |
| EBITDA Margin | 29.10% |
| EBIT Margin | 25.41% |
| FCF Margin | 14.02% |
Dividends & Yields
This stock pays an annual dividend of 5.35, which amounts to a dividend yield of 1.62%.
| Dividend Per Share | 5.35 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | -74.04% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 34.48% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.58% |
| Earnings Yield | 4.57% |
| FCF Yield | 2.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 25, 2017. It was a forward split with a ratio of 5.
| Last Split Date | May 25, 2017 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
NSE:ADVENZYMES has an Altman Z-Score of 15.62 and a Piotroski F-Score of 6.
| Altman Z-Score | 15.62 |
| Piotroski F-Score | 6 |